Novo Nordisk shares higher on positive Phase 3 trial results for obesity drug Cagrilintide US$ 29.44 Min. order: 1 piece ★★★★★ 4.0 (93 reviews) Sold : Login>>
PRP Injection for Knee Pain Relief US$ 26.81 Min. order: 1 piece ★★★★★ 4.8 (190 reviews) Sold : Login>>
Novo Nordisk files for FDA approval for CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues US$ 23.01 Min. order: 1 piece ★★★★★ 4.2 (177 reviews) Sold : Login>>
Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme US$ 27.05 Min. order: 1 piece ★★★★★ 4.8 (211 reviews) Sold : Login>>
Novo Nordisk Aims for the Top: CagriSema Poised for Breakthrough US$ 22.88 Min. order: 1 piece ★★★★★ 4.6 (203 reviews) Sold : Login>>
Novo Nordisk's experimental obesity drug CagriSema shows blood pressure benefits US$ 27.47 Min. order: 1 piece ★★★★★ 5.0 (259 reviews) Sold : Login>>